Pinomax Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Investors
-
9
Pinomax General Information
Description
Developer of medical imaging technologies intended to provide image analysis and develop healthcare diagnostics. The company's technology is specialized for segmentation of MRI and CT-based images for diagnosing degenerative diseases of the brain, such as dementia and Parkinson's disease, and its medical image technology compartmentalizes specific parts of breast cancer, thyroid cancer, as well as liver cancer, enabling medical practitioners to execute digital-physical wellness for patients' wellness.
Contact Information
Website
www.pmx-inc.comCorporate Office
- Room 309, 3rd Foor, 46 Bulding A
- Dallaenae, Sujeong
- Seoul, Gyeonggi
- South Korea
Corporate Office
- Room 309, 3rd Foor, 46 Bulding A
- Dallaenae, Sujeong
- Seoul, Gyeonggi
- South Korea
Pinomax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A) | 24-Dec-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 18-Oct-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 21-Jun-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Mar-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Aug-2020 | $1.3M | $1.3M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 25-Feb-2020 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pinomax Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pinomax Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pinomax Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNK Venture Capital | Venture Capital | Minority | ||
| InterValue Partners | Venture Capital | Minority | ||
| Korea Alternative Investment Corporation | Asset Manager | Minority | ||
| Astralabs | Accelerator/Incubator | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority |
Pinomax FAQs
-
When was Pinomax founded?
Pinomax was founded in 2020.
-
Where is Pinomax headquartered?
Pinomax is headquartered in Seoul, South Korea.
-
What is the size of Pinomax?
Pinomax has 7 total employees.
-
What industry is Pinomax in?
Pinomax’s primary industry is Diagnostic Equipment.
-
Is Pinomax a private or public company?
Pinomax is a Private company.
-
What is Pinomax’s current revenue?
The current revenue for Pinomax is .
-
How much funding has Pinomax raised over time?
Pinomax has raised $4.83M.
-
Who are Pinomax’s investors?
BNK Venture Capital, InterValue Partners, Korea Alternative Investment Corporation, Astralabs, and Tech Incubator Program for Startup are 5 of 9 investors who have invested in Pinomax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
